Data / New clinical trials / Côte d’Ivoire
New clinical trials in Côte d’Ivoire: 21 since Nov 2024
The full list. New clinical trials with a site in Côte d’Ivoire: 21 rows for $5, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 1 row a month. The new rows come each week by email, $19 a month.
$10 of credit on sign-up, no card. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. To get the new rows in your own tools, use SpecStream on Zapier.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/c-te-d-ivoire, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 4, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
21 clinical studies with a site in Côte d’Ivoire were first posted on ClinicalTrials.gov from November 21, 2024 to November 4, 2026; 7 have an industry sponsor and 14 are recruiting or about to. The newest, NCT07915518, was posted on November 4, 2026: A Phase III Trial to Evaluate the Safety and Efficacy of Anti-inflammatory Drugs in Addition to Praziquantel... (Brian Ngwira).
The request: Every new clinical trial with a site in Côte d’Ivoire, with the sponsor, phase, conditions and the listed contact.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 21New trials
- 7Industry sponsored
- 14Recruiting or not yet
- November 4, 2026Latest posted
Newest trials
The newest 21 of 21, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 4, 2026 | NCT07915518 | A Phase III Trial to Evaluate the Safety and Efficacy of Anti-inflammatory Drugs in Addition to Praziquantel in Girls and Women With Female... | Brian Ngwira | Phase 3 | Not yet recruiting | Female Genital Schistosomiasis | 800 | Côte d’Ivoire, Democratic Republic of the Congo, Ghana, Malawi | clinicaltrials.gov |
| September 14, 2026 | NCT07819201 | Improving Maternal and Neonatal Care-seeking Through a Video-informed Training Session During the Third Trimester of Pregnancy | Swiss Tropical & Public Health Institute | Not applicable | Not yet recruiting | Maternal Health, Neonatal Health, Pregnancy, Postpartum Care | 800 | Côte d’Ivoire | clinicaltrials.gov |
| September 10, 2026 | NCT07811908 | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria... | Novartis Pharmaceuticals | Phase 2 | Recruiting | Uncomplicated Plasmodium Falciparum Malaria | 120 | Burkina Faso, Côte d’Ivoire, Gabon, Ghana, Kenya, Rwanda, Uganda | clinicaltrials.gov |
| September 10, 2026 | NCT07811882 | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria... | Novartis Pharmaceuticals | Phase 2 | Completed | Uncomplicated Plasmodium Falciparum Malaria | 95 | Burkina Faso, Côte d’Ivoire, Gabon, Ghana, Kenya, Rwanda, Uganda | clinicaltrials.gov |
| September 8, 2026 | NCT07807202 | Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-up | Arsène Brunelle Sandie | Not applicable | Completed | Papillomavirus Infections, Uterine Cervical Neoplasms | 17,188 | Côte d’Ivoire, Mali | clinicaltrials.gov |
| June 9, 2026 | NCT07636629 | Evaluation of "C'Est La Vie!" Digital Health Education | University of California, Los Angeles | Not applicable | Completed | Health Education, Health Communication | 492 | Burkina Faso, Côte d’Ivoire, Senegal | clinicaltrials.gov |
| May 6, 2026 | NCT07569172 | Improved Child Nutrition and Development Through Social Transfers | Swiss Tropical & Public Health Institute | Not applicable | Not yet recruiting | Breastfeeding, Breastfeeding Education, Breastfeeding Duration, Breastfeeding Continuation, Child Growth, Stress... | 1,040 | Côte d’Ivoire | clinicaltrials.gov |
| March 23, 2026 | NCT07488520 | Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire | Swiss Tropical & Public Health Institute | Phase 4 | Recruiting | Sickle Cell Disease (SCD) | 120 | Côte d’Ivoire | clinicaltrials.gov |
| March 20, 2026 | NCT07486778 | Taabo Tutoring Study | San Diego State University | Not applicable | Recruiting | Secondary School Entry and Completion, Education Advancement, School Attendance, Educational Attainment, Academic... | 1,000 | Côte d’Ivoire | clinicaltrials.gov |
| January 21, 2026 | NCT07355413 | Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West Africa | ANRS, Emerging Infectious Diseases | Observational | Recruiting | Older Adults | 600 | Burkina Faso, Côte d’Ivoire, Togo | clinicaltrials.gov |
| January 14, 2026 | NCT07341581 | Improving Uptake of Antenatal Care Services in Rural Côte d'Ivoire | Swiss Tropical & Public Health Institute | Not applicable | Recruiting | Uptake of Antenatal Health Care Services | 1,290 | Côte d’Ivoire | clinicaltrials.gov |
| November 19, 2025 | NCT07235033 | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria... | Novartis Pharmaceuticals | Phase 2 | Completed | Uncomplicated Plasmodium Falciparum Malaria | 60 | Côte d’Ivoire, Gabon, Kenya | clinicaltrials.gov |
| November 19, 2025 | NCT07235020 | Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria | Novartis Pharmaceuticals | Phase 2 | Completed | Uncomplicated Plasmodium Falciparum Malaria | 52 | Burkina Faso, Côte d’Ivoire, Gabon, Ghana, Kenya, Uganda | clinicaltrials.gov |
| September 22, 2025 | NCT07186205 | A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Risk of Iron Deficiency and Anaemia in African... | Danone Asia Pacific Holdings Pte, Ltd. | Observational | Completed | Iron Deficiencies | 126 | Côte d’Ivoire | clinicaltrials.gov |
| September 15, 2025 | NCT07172659 | Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction | Medicines Development for Global Health | Phase 2 | Recruiting | Erythema Nodosum Leprosum | 45 | Benin, Côte d’Ivoire, Indonesia, Madagascar, Philippines, United States | clinicaltrials.gov |
| September 12, 2025 | NCT07170748 | Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis) | MagIA Diagnostics | Observational | Recruiting | Multiplex Testing of HIV, HBV, HCV and Syphilis, HIV, HBV, HCV, Syphilis, Point of Care Testing | 2,950 | Côte d’Ivoire, Kenya | clinicaltrials.gov |
| July 16, 2025 | NCT07069400 | An International Observational Study of Adults With Acute Infection | University of Minnesota | Observational | Recruiting | Infectious Disease | 1,500 | Argentina, Australia, Brazil, Côte d’Ivoire, Denmark, France, Germany, Greece... | clinicaltrials.gov |
| June 8, 2025 | NCT07009847 | An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine | Serum Institute of India Pvt. Ltd. | Observational | Recruiting | Malaria,Falciparum, Morality | 2,308 | Burkina Faso, Côte d’Ivoire, Nigeria, Uganda | clinicaltrials.gov |
| May 30, 2025 | NCT06997705 | Integrated HPV Vaccination and Adolescent Health in Ivory Coast | Jhpiego | Not applicable | Recruiting | Integrated Care, HPV Vaccination, Adolescent | 3,384 | Côte d’Ivoire | clinicaltrials.gov |
| February 3, 2025 | NCT06804902 | MaCRA Part B in Côte d'Ivoire | PATH | Not applicable | Withdrawn | Malaria | 0 | Côte d’Ivoire | clinicaltrials.gov |
| November 21, 2024 | NCT06698510 | Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public... | Peter Steinmann | Observational | Recruiting | Schistosomiasis | 18,500 | Côte d’Ivoire, Kenya, Uganda | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Swiss Tropical & Public Health Institute | 4 | September 14, 2026 |
| Novartis Pharmaceuticals | 4 | September 10, 2026 |
| Brian Ngwira | 1 | November 4, 2026 |
| Arsène Brunelle Sandie | 1 | September 8, 2026 |
| University of California, Los Angeles | 1 | June 9, 2026 |
| San Diego State University | 1 | March 20, 2026 |
| ANRS, Emerging Infectious Diseases | 1 | January 21, 2026 |
| Danone Asia Pacific Holdings Pte, Ltd. | 1 | September 22, 2025 |
| Medicines Development for Global Health | 1 | September 15, 2025 |
| MagIA Diagnostics | 1 | September 12, 2025 |
| University of Minnesota | 1 | July 16, 2025 |
| Serum Institute of India Pvt. Ltd. | 1 | June 8, 2025 |
| Jhpiego | 1 | May 30, 2025 |
| PATH | 1 | February 3, 2025 |
| Peter Steinmann | 1 | November 21, 2024 |
Conditions
| Condition group | New trials | Latest |
|---|---|---|
| Malaria, Falciparum | 5 | September 10, 2026 |
| Communicable Diseases | 2 | May 6, 2026 |
| Anemia | 2 | May 6, 2026 |
| Malaria | 2 | June 8, 2025 |
| Stillbirth | 1 | September 14, 2026 |
| Papillomavirus Infections | 1 | September 8, 2026 |
| Uterine Cervical Neoplasms | 1 | September 8, 2026 |
| Health Education | 1 | June 9, 2026 |
| Breast Feeding | 1 | May 6, 2026 |
| Weight Loss | 1 | May 6, 2026 |
| Psychological Well-Being | 1 | May 6, 2026 |
| Diarrhea | 1 | May 6, 2026 |
| Cough | 1 | May 6, 2026 |
| Eczema | 1 | May 6, 2026 |
| Hypersensitivity | 1 | May 6, 2026 |
| Anemia, Sickle Cell | 1 | March 23, 2026 |
| Frailty | 1 | January 21, 2026 |
| Iron Deficiencies | 1 | September 22, 2025 |
| Hepatitis B | 1 | September 12, 2025 |
| Hepatitis C | 1 | September 12, 2025 |
| Syphilis | 1 | September 12, 2025 |
| Death | 1 | June 8, 2025 |
| Schistosomiasis | 1 | November 21, 2024 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 8 | September 14, 2026 |
| Observational | 6 | January 21, 2026 |
| Phase 2 | 5 | September 10, 2026 |
| Phase 3 | 1 | November 4, 2026 |
| Phase 4 | 1 | March 23, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.
$10 of credit on sign-up, no card.